ClinicalTrials.gov record
Recruiting Phase 1 Interventional

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

ClinicalTrials.gov ID: NCT06751238

Public ClinicalTrials.gov record NCT06751238. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 3:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Multicenter Study to Evaluate Pharmacokinetics, Safety and Tolerability up to 6 Years of Intravenous Secukinumab Infusions in Pediatric Participants With Juvenile Psoriatic Arthritis

Study identification

NCT ID
NCT06751238
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
20 participants

Conditions and interventions

Interventions

  • Secukinumab Biological

Biological

Eligibility (public fields only)

Age range
2 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 23, 2025
Primary completion
Nov 29, 2032
Completion
Nov 30, 2032
Last update posted
Mar 10, 2026

2025 – 2032

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
University of Florida Gainesville Florida 32610 8068 Recruiting
Ann and Robert H Lurie Childs Hosp Chicago Illinois 60611 Recruiting
Levine Childrens Hospital Charlotte North Carolina 28203 Recruiting
Cincinnati Childrens Hospital Cincinnati Ohio 45229 Recruiting
Univ Hosp Cleveland Medical Center Cleveland Ohio 44106-5028 Recruiting
Legacy Emanuel Research Hosp Portland Portland Oregon 97232 Recruiting
Texas Arthritis Center El Paso Texas 79902 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06751238, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06751238 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →